Hepaglide 0.25 mg Injection
In stock
Description
Hepaglide 0.25 mg Injection is a weekly subcutaneous,, prescription-based, semaglutide-based medication used to manage type 2 diabetes, obesity, and weight loss. It is a GLP-1 receptor agonist that acts by lowering blood sugar, slowing digestion, and reducing appetite and typically supplied in a prefilled multi-dose pen with needles.
Specifications
| Strength | 0.25 mg |
|---|---|
| Storage | 2–8°C (Cold Chain Logistics) |
| Therapeutic Class | GLP-1 (Glucagon-Like Peptide-1) Receptor Agonist |
| Main Ingredients | Semaglutide |
